Physician profile
Peter Wu
NPI 1760696371
$4,329.32
in general payments reported to CMS, 2019-2025
11 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2020: $27.31 · 2021: $241 · 2022: $296 · 2023: $1,608 · 2024: $634 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,794 · Travel and Lodging: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,794.02 |
| Travel and Lodging | $866.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,373.34 | 2023-2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Kci USA, INC. | $952.94 | 2019-2021 | |
| Mentor Worldwide LLC | $609.98 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sanara Medtech INC. | $351.04 | 2024-2025 | Celleraterx, Celleraterx |
| Janssen Pharmaceuticals, INC | $278.01 | 2022-2024 | Xarelto |
| Stryker Corporation | $196.82 | 2024 | Vsp System, Vsp Cranial, Na |
| Merck Sharp & Dohme LLC | $169.13 | 2019-2025 | Bridion |
| Derma Sciences, INC. | $140.81 | 2019 | |
| Acumed LLC | $128.70 | 2025 | Osteomed |
| Sientra, INC. | $70.07 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $58.48 | 2022-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.